Mid-cap pharma stocks to buy: Volatility is temporary, fundamental tailwinds are permanent: 5 mid-cap pharma stocks with an upside potential of up to 46%

Published:



Recently, an Indian pharma company announced its intention to take over a reasonably-sized European firm. This is more than a one-off event. It reflects a change in the underlying operating matrix of the pharma industry which, for the last many years, has been going through a period of readjustment and is now coming into its own. The readjustment was not just in terms of valuations, but, more importantly, in terms of operations. In a business



Source link

Related articles

spot_img

Recent articles